To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

Clinical trial NCT00363545 · COMPLETED

Trial details

NCT number: NCT00363545
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2006-09-01
Primary completion: 2007-04-12
Enrollment: 1274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.